Cargando…
Cytochrome P450 Metabolism of Betel Quid-Derived Compounds: Implications for the Development of Prevention Strategies for Oral and Pharyngeal Cancers
Betel quid (BQ) products, with or without tobacco, have been classified by the International Agency for Research on Cancer (IARC) as group I human carcinogens that are associated with an elevated risk of oral potentially malignant disorders (OPMDs) and cancers of the oral cavity and pharynx. There a...
Autores principales: | Lin, Che-Yi, Pan, Tien-Szu, Ting, Chun-Chan, Liang, Shih-Shin, Huang, Shu-Hung, Liu, Hsiu-Yueh, Ko, Edward Cheng-Chuan, Wu, Chung-Wei, Tang, Jen-Yang, Chen, Ping-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747400/ https://www.ncbi.nlm.nih.gov/pubmed/23983642 http://dx.doi.org/10.1155/2013/618032 |
Ejemplares similares
-
Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers
por: Chen, Ping-Ho, et al.
Publicado: (2017) -
The Influence of Monoamine Oxidase Variants on the Risk of Betel Quid-Associated Oral and Pharyngeal Cancer
por: Chen, Ping-Ho, et al.
Publicado: (2014) -
Genomic Alterations in Breast Cancer Patients in Betel Quid and Non Betel Quid Chewers
por: Kaushal, Mishi, et al.
Publicado: (2012) -
CYP26A1 Is a Novel Biomarker for Betel Quid-Related Oral and Pharyngeal Cancers
por: Chen, Ping-Ho, et al.
Publicado: (2020) -
Development and Validation of a Self-Administered Screening Test for Betel Quid Use Disorders in Betel Quid Chewers in Hunan, China
por: Yang, Lei, et al.
Publicado: (2022)